Back to Show
PBS News Hour
FDA criticized for Alzheimer's drug approval process
New findings from a congressional investigation into the Food and Drug Administration and the biotech company Biogen find the FDA broke its own protocols to approve a new Alzheimer’s drug last year. The report said the FDA worked too closely with Biogen despite significant concerns over the limited benefits and side effects of the new drug, Aduhelm. Geoff Bennett reports.
Support Provided By
Season

26:45
April 20, 2025 - PBS News Weekend full episode

26:44
April 19, 2025 - PBS News Weekend full episode

57:46
April 18, 2025 - PBS News Hour full episode

57:46
April 17, 2025 - PBS News Hour full episode

57:46
April 16, 2025 - PBS News Hour full episode

57:46
April 15, 2025 - PBS News Hour full episode

57:46
April 14, 2025 - PBS News Hour full episode

26:44
April 13, 2025 - PBS News Weekend full episode

26:45
April 12, 2025 - PBS News Weekend full episode

57:46
April 11, 2025 - PBS News Hour full episode

57:46
April 10, 2025 - PBS News Hour full episode

57:46
April 9, 2025 - PBS News Hour full episode